Actively Recruiting
Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection
Led by National Institute of Respiratory Diseases, Mexico · Updated on 2024-08-01
310
Participants Needed
1
Research Sites
153 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The aim of this study is to analyze the effect of enriched formula with omega-3 in the 30-day incidence infection and inflammatory response following lung resection surgery in lung cancer patients.
CONDITIONS
Official Title
Nutritional Therapy Enriched With Omega-3 in Patients With Lung Resection
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of lung cancer
- Scheduled elective lung resection surgery at least four days in advance
- Signed informed consent
You will not qualify if you...
- Acute or chronic organ failure such as liver or kidney insufficiency
- Known allergy to fish
- History of any surgery within the past 3 months
- Being immunocompromised
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
National Institute of Respiratory Diseases
Mexico City, Mexico, 14080
Actively Recruiting
Research Team
I
Ivan A Osuna-Padilla, PhD
CONTACT
A
Ana L Gómez-Rodriguez, MSc
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
PREVENTION
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here